Persistent Asset Partners Ltd
- SEC CIK
- 0002056052
- Latest filing
- Aug 6, 2026
URGN holding history
UroGen Pharma Ltd. in every 13F filed by Persistent Asset Partners Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
URGN overviewAll 13F holders of URGNFull Q2 2026 holdings
- Shares (Q2 2026)
- 1,790
- Value
- $65.9K
- % of portfolio
- <0.1%
- Quarters held
- 6
- Since Q1 2025
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 1,790 | $65.9K | <0.1% | −4,034−69.3% | Reduced | Holders |
| Q1 2026 | 5,824 | $104.7K | <0.1% | −6,982−54.5% | Reduced | Holders |
| Q4 2025 | 12,806 | $299.9K | 0.1% | −7,920−38.2% | Reduced | Holders |
| Q3 2025 | 20,726 | $413.5K | 0.3% | −13,874−40.1% | Reduced | Holders |
| Q2 2025 | 34,600 | $474.0K | 0.4% | +17,029+96.9% | Added | Holders |
| Q1 2025 | 17,571 | $194.3K | 0.2% | +17,571 | New | Holders |